"The medication's going to be 50 percent of your journey, and the other 50 percent is still what you choose to eat and the ...

More people are reporting experiencing potentially dangerous side effects after using slimming drugs, the national toxicology ...

The number of people poisoned by the incorrect use of weight loss medication is on the rise in the Netherlands. Last year, ...

As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs for millions of people.

Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.

As drug development increasingly targets multiple indications, pharma companies must make strategic branding ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Mounjaro offers up to 20% weight loss – but it’s not for everyone. Learn about eligibility, alternatives and why long-term habits still matter most.

As the NHS rolls out Mounjaro being prescribed by GPs, weight loss jabs have been linked to potentially fatal side effects in new data ...

These six stocks span numerous sectors, providing investors with opportunities in both growth and dividend yield.